A US Court dismisses the complaint of Bloomberg filed against the Commodity Futures Trading Commission.
Industry
UPDATE: Elan Rejects Fresh Bid from Royalty
Elan rejects the newest bid from Royalty and seeks to look at other unsolicited interested parties.
AstraZeneca Acquires Pearl Therapeutics for US$1.15 Billion
AstraZeneca purchases Pearl Therapeutics for US$1.15 billion, making it the second firm in Britain to rebuild products through deal making.
Nok Air and AirAsia X to Raise Funds in IPO
Amid the booming air travel industry, Nok Air and AirAsia X announced IPO for their shares to be used for the companies' expansion plans.
Marubeni Leaves Energy Arm In Gavilon’s Deal
Japan’s Marubeni said that it will leave Gavilon’s energy arm from the proposed takeover deal. (Photo : REUTERS)Logo of Marubeni Corp is seen at the company's head office in Tokyo Marubeni Corp, a Japanese trading house states that it will cut its planned takeover deal over Gavilon's energy business.
Latest News
Raiffeisen Bank International Chairman says that it would tighten compliance rules due to the latest Stepic controversy.
French President Francois Hollande calls out European Union to resolve the row with China on importations.
CIC VP was quoted as saying that CIC's overseas investment portfolio grew in 2012. (Photo : Reuters)The image is CIC Chairman Lou Jiwei. China Investment Corp, the sovereign wealth fund of China, has reportedly said that it had increased its overseas investment returns by 11% in 2012 after reporting a loss back in 2011.
US Bankruptcy Court Judge, Christopher Sontchi granted planned acquisition deal without legal challenge between Micron Technologies Inc. and Elpida Memory Inc.
Marubeni Corp. is in advanced discussions to takeover Gavilon's energy division at US$5.6 billion.
Deutsche Bank has arranged a US$200 million credit line for Apollo Global Management LLC as a means to purchase single family rental homes in the US.
Twilio Inc. raised US$70 million from venture capitalists where funding was headed by Redpoint Ventures.
The Ontario Teachers Pension Plan will vote for the Sprint-SoftBank deal as it is the fifteenth biggest shareholder in Sprint Nextel Corp.
Royalty Pharma raised its hostile bid for Irish drug firm, Elan from US$12.50 to US$13. (Photo : Reuters)The image is the corporate logo of Royalty Pharma, the healthcare focused equity fund.
